2022 INOVA HEART AND VASCULAR INSTITUTE ACHIEVEMENTS

We are grateful to the Dudley family for their continued support for the Inova Dudley Family Center for Cardiovascular Innovation.

We’ve continued to strengthen community partnerships with other hospitals throughout the region through our care model for treating cardiogenic shock. Inova has provided a blueprint for excellence that has had an impact throughout the DC metro region, nationally and internationally The efficacy of this care model is highlighted once again through publications in prestigious journals.

9th in the U.S. in heart transplant volume and our survival rate is excellent. Improvements in care delivery are evident in our approach to managing and treating heart failure.

Recent innovations in our cardiac surgery program, including the use of robotically assisted minimally invasive techniques, open the option for bypass surgery to patients who would otherwise not have been surgical candidates due to frailty, co-morbidities or social factors

Our specially trained surgery team led by Dr. Ramesh Singh is the first in Northern Virginia and one of a few select centers in the US to offer this option. Patients have fewer risks, experience less pain and bleeding, and recover in days instead of months.

Tremendous gains have been made in the treatment of valvular disease with transcatheter valve replacement and repair procedures. Early identification is key along with the development of new targeted and personalized strategies to predict the likelihood of major adverse cardiac events post-procedure.

The Inova Heart and Vascular Institute Structural Heart Team achieved national prominence by performing two live cases for the 2022 Society for Cardiovascular Angiography and Interventions Scientific Sessions: A high-risk, Impella-supported percutaneous coronary intervention and a technically challenging transcatheter aortic valve replacement. Outcomes were excellent, thanks to the amazing work of the teams.

For the second consecutive year, our team received the Mitral Valve Repair Reference Center Award from the American Heart Association and the Mitral Foundation for our demonstrated record of superior clinical outcomes. In early 2022, the Structural Heart Team celebrated their 200th MitraClip procedure. We are the highest volume program in the Washington, DC Metro region and among the top volume programs in the east. The team has also implanted 500 Watchman Devices to reduce the risk of stroke in patients with non-valvular atrial fibrillation.